EU Directives are not working for products used in CAM

The CAM Interest Group meeting of 16 November 2010 was dedicated to discussions on the availability of CAM products.
In Europe the availability of CAM products, including homeopathic, anthroposophic and herbal medicinal products, is increasingly being reduced by unnecessarily onerous requirements and restrictions that are leading to prohibitive costs for manufacturers. This thwarts the growing demand of European citizens for more natural, health enhancing, low-risk medicinal products as well as the ability to practise of doctors and practitioners. Urgent discussions are needed to explore avenues for developing a more appropriate legal framework that allows the continuing viability of these products.

Presentations and documents available for downloading:

schaduw